Download the 2016 Conference Brochure

Download Now

Leading International Expert Speakers

Why 7th Digital Pharma West Is the Number One Provider of Content, Innovation and Practical Insights on the West Coast.

Pharmaceutical and medical device companies of ALL sizes and scales need to understand how pharma can ensure that digital is part of their company's DNA. It's not just about doing better digital marketing, it's about embedding digital into everything you do across divisions — from the earliest R&D to postmarketing/commercial. It's about how you communicate and collaborate across "yourselves" and even how you find and recruit talent to improve your business.

Delivering better outcomes through innovative digital initiatives with patient co-creation at the heart. Together as an industry, we can build a business that will:

• Put patients first
Think patient
• Empower the empowered patient
• Truly get why patients matter
Understand why patients are at the center of what we do
• Deliver the patient experience
• Go beyond the patient — people
• Recognize that people are at the heart of every patient

Who is your customer in 2016? In previous years it was "all about the HCP." Physicians continue to be the major goal in engagement, education and access. Additionally, the growth of pharmacies as a venue of health management is a dynamic shift. Pharmacies are shifting to become health delivery agents for the patients, and the patient journey/experience engenders many objectives and questions that pharma must consider. All of this means there are challenges and questions that need answering, but where do we start?

• The innovation landscape today: What can we do to solve current business challenges with innovation, and how can we incorporate innovation teams with marketing, IT, regulatory, and even R&D?
The need for an overarching, global consumer engagement strategy: What is the level of innovation needed and how can we differentiate with offerings, not just price?
The gap between “pharma speed” and “digital speed”: How and what can we leverage from other sectors to help us bridge the gap?
Whether pharma can move past the absence of a “fail fast” mentality: Can pharma adopt a company culture that is less risk averse and lends itself to improved operational efficiency to allow for more innovative tools and offerings?
• Pharmacy engagement: How can we establish pharmacy engagement as a growing part of the value chain?

The road to delivering true customer centricity and an experience that connects customers to your brand means that pharma needs to adapt. In order to transition from an assets position to a solutions one, pharma needs to address an important question: How can we launch for a solution, not just a product?

• What would you define as a “solution”? What would you measure differently?
• "Solutioning" implies outside the comfort zone thinking. How does your organization support that? Is innovation just a buzzword?
• What models or methods would you recommend marketers leverage to build solutions? E.g., journey mapping, design thinking and script journey.
• Pharma's innovation landscape today needs work. How can we solve current and future unmet market needs?
• There is value beyond the pill, and we need to actually go beyond a Patient Hub. But where does "beyond" take us from an executional perspective?
• Can pharma adopt a company culture that is less risk averse and lends itself to improved operational efficiency to allow for more innovative tools and offerings? Will this deliver solutions?
• How do you support ways of working within a cross-functional environment that balances speed, relevance, demands and utility to get where we want to be, in terms rolling out solutions?
• What should you look for in a partner? How do you partner with specialty vendors that provide services?
• What are the key KPIs for solutions? How do you bridge KPIs to program return(s)?
• Technology while being an enabler can also take time to build and deploy. How do you all overcome IT bottlenecks to deliver solutions?

How do we manage the role of data insights, overcome in-house capabilities and limitations, and store data internally in order to start working on and delivering solutions?

• How are How are pharma marketers using people, processes and technologies to separate the signal from the noise inherent in all data types?
• Can pharma marketers truly cross the chasm (think of magnitudes of the Ministries of Health, the FDA, Health Canada, and the European Medicines Agency) in leveraging the “wellness data” locked in the consumer/payer market(s) to deliver patient engagement programs that create value in key therapy areas?
• Now that we have sales force automation and marketing automation in place, how can we make sure that fallible humans do not make these systems fallible? Can we ever do CLM effectively?
• What has worked in marketing mix modeling? What has not? How can you get senior leadership to buy into the ways of working in this digital world? How can we best set up a framework of governance to measure and act on both leading and lagging indicators relative to brand marketing initiatives?
• How can we leverage data to be the common glue that builds relationships with legal, compliance, regulatory and R&D functions? How can we deploy AE and PV processes that deliver compliance and insights?
• What about the smaller guys? In smaller companies, many other functions do not fully appreciate the commercial technologies built prelaunch. How can we break down the walls between groups? E.g., Can call trees serve your medical information group to capture AEs post-launch?
• The dreaded three letter word – ROI. What gets measured gets done. Therefore, how do we measure the right things accurately?

Our Sponsors

Purchase the 2015 Conference Documentation

Purchase Now

Download the 2016 Conference Brochure

Download Now